ArticleBone marrow transplantation2024

Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program.

Thirupathi Pattipaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.